Brookline, MA, United States of America

Marc B Garnick

USPTO Granted Patents = 18 

Average Co-Inventor Count = 2.2

ph-index = 8

Forward Citations = 369(Granted Patents)


Company Filing History:


Years Active: 1993-2010

Loading Chart...
18 patents (USPTO):Explore Patents

Title: The Innovative Mind of Marc B. Garnick

Introduction

Marc B. Garnick, an accomplished inventor based in Brookline, MA, holds an impressive portfolio of 18 patents. His work primarily revolves around biotechnology, specifically addressing amyloid aggregation and hormone-related conditions. Garnick’s contributions have the potential to influence the development of treatments for various medical conditions.

Latest Patents

One of Garnick's latest patents focuses on **modulators of amyloid aggregation**. This innovation discloses compounds that can modulate the aggregation of amyloidogenic proteins or peptides, either promoting or, more preferably, inhibiting natural amyloid aggregation. A notable aspect of his invention is that the compounds contain an Aβ aggregation core domain, which can alter the aggregation or reduce the neurotoxicity of natural β amyloid peptides upon contact. Moreover, these modulators are effective even when the natural β-APs are in a molar excess relative to the modulators. His patent also encompasses pharmaceutical compositions featuring these compounds and methods for diagnosing and treating amyloidogenic diseases.

Another significant development in his patent portfolio includes **methods for treating FSH related conditions** using GnRH antagonists. This invention provides methods to treat conditions such as prostatic intraepithelial neoplasia and infertility, by administering a suitable GnRH antagonist that effectively reduces both plasma FSH and LH levels. His innovative approach also includes developing in vitro fertilization and male contraceptive methods.

Career Highlights

Throughout his illustrious career, Marc B. Garnick has worked with prominent pharmaceutical companies such as Praecis Pharmaceuticals, Inc. and Genetics Institute, Inc., where he focused on legal affairs. His work in these organizations has allowed him to bridge the gap between scientific innovation and legal frameworks, a crucial aspect in the realm of patents and intellectual property.

Collaborations

Marc has collaborated with notable individuals in the field, including Malcolm L. Gefter and Christopher J. Molineaux. These collaborations highlight the interdisciplinary nature of his work and the importance of teamwork in advancing innovative solutions in biotechnology.

Conclusion

Marc B. Garnick's contributions to the field of biotechnology through his patented innovations showcase his remarkable expertise and dedication. His work not only aims to advance the understanding of amyloid aggregation and hormone-related conditions but also lays the groundwork for future developments in therapeutic treatments. As he continues to innovate, the impact of his inventions may lead to significant advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…